Tectonic Therapeutic Appoints New Director
Ticker: TECX · Form: 8-K · Filed: Jul 5, 2024 · CIK: 1681087
| Field | Detail |
|---|---|
| Company | Tectonic Therapeutic, Inc. (TECX) |
| Form Type | 8-K |
| Filed Date | Jul 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-appointment, governance
TL;DR
Tectonic adds Dr. Weaver to the board, effective June 28, 2024.
AI Summary
Tectonic Therapeutic, Inc. announced on June 28, 2024, the election of Dr. Jonathan G. Weaver as a Class III Director, effective immediately. Dr. Weaver, who has extensive experience in the biotechnology sector, will serve on the Audit Committee and the Compensation Committee. This appointment is part of the company's ongoing efforts to strengthen its board with experienced leadership.
Why It Matters
The addition of an experienced director like Dr. Weaver can bring valuable strategic insights and governance oversight, potentially influencing the company's future direction and investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns a routine board appointment and does not involve significant financial transactions or operational changes.
Key Players & Entities
- Tectonic Therapeutic, Inc. (company) — Registrant
- Jonathan G. Weaver (person) — Newly elected Class III Director
- June 28, 2024 (date) — Effective date of director election
FAQ
Who is the new director appointed to Tectonic Therapeutic's board?
Dr. Jonathan G. Weaver was elected as a Class III Director.
When was the election of the new director effective?
The election was effective as of June 28, 2024.
What committees will Dr. Weaver serve on?
Dr. Weaver will serve on the Audit Committee and the Compensation Committee.
What is Tectonic Therapeutic, Inc.'s state of incorporation?
Tectonic Therapeutic, Inc. is incorporated in Delaware.
What is Tectonic Therapeutic, Inc.'s business address?
The business address is 490 Arsenal Way, Suite 210, Watertown, MA 02472.
Filing Stats: 630 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2024-07-05 16:05:55
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share TECX Nasdaq Global Market
Filing Documents
- d859790d8k.htm (8-K) — 26KB
- d859790dex101.htm (EX-10.1) — 40KB
- 0001193125-24-175599.txt ( ) — 199KB
- tecx-20240628.xsd (EX-101.SCH) — 3KB
- tecx-20240628_lab.xml (EX-101.LAB) — 18KB
- tecx-20240628_pre.xml (EX-101.PRE) — 11KB
- d859790d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Separation Agreement, dated July 5, 2024, between Tectonic Therapeutic, Inc. and Christian Cortis. 104 Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TECTONIC THERAPEUTIC, INC. Date: July 5, 2024 By: /s/ Daniel Lochner Daniel Lochner Chief Financial Officer